China · Biotechnology
Biotechnology
Cancer early detection is probably the most cost-effective means to reduce cancer mortality as prognosis is much better when cancer is detected and treated at the early stage. SeekIn is a startup focusing on blood-based pan cancer early diagnosis with a mission to reduce cancer mortality by 10% in the screened population by 2030. Our proprietary ctDNA mutation detection technology has demonstrated its promise to identify asymptomatic cancer patients from general population.
2018
Founded
Biotechnology
Industry
China
Location
289,416,237
Ranking
6 employees
Size
Get full access to view complete information
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
